{
  "question": "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) change of protein conformation and gain-of-function phenotype\nB) protein aggregation and loss-of-function phenotype\nC) loss of protein dimerization and wild-type phenotype\nD) protein degradation and loss-of-function of the wild-type allele\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>",
  "response_list": [
    "A detailed analysis of the provided scenario points to a specific molecular outcome for the transcription factor with mutation Y. Here's a breakdown of the reasoning:\n\n*   **Understanding the Wild-Type Function:** The transcription factor normally exists as a monomer. Upon receiving a signal (phosphorylation), it forms a dimer, moves into the nucleus, and activates gene transcription. Dimerization is a critical step for its function.\n\n*   **Mutation X as a Reference:** Mutation X is a recessive loss-of-function mutation in the transactivation domain. This means that if one normal allele and one \"X\" allele are present, the normal protein can still form functional dimers and carry out transcription, so no disease phenotype is observed. The loss-of-function phenotype only appears when both alleles have the \"X\" mutation.\n\n*   **The Nature of Mutation Y:** Mutation Y is in the dimerization domain and acts as a dominant-negative mutation. This is the most critical piece of information. A dominant-negative mutation produces a faulty protein that interferes with the function of the normal protein produced by the wild-type allele.\n\n*   **Mechanism of Dominant-Negative Action:** In the context of a dimeric protein, a dominant-negative mutation often allows the mutant protein to still interact with the wild-type protein. In a heterozygous individual with one wild-type allele and one \"Y\" allele, three types of dimers can potentially form:\n    *   Wild-type + Wild-type: Functional\n    *   Wild-type + Mutant Y: Non-functional\n    *   Mutant Y + Mutant Y: Non-functional\n\n    Because the mutant Y protein can bind to and inactivate the wild-type protein, the overall level of functional transcription factor is drastically reduced, leading to a loss-of-function phenotype even with a normal allele present. This \"poisoning\" of the wild-type protein is the hallmark of a dominant-negative effect.\n\n*   **Evaluating the Options:**\n    *   **A) change of protein conformation and gain-of-function phenotype:** This is incorrect. A dominant-negative mutation causes a *loss-of-function*, not a gain-of-function where the protein would acquire a new, uncontrolled activity.\n    *   **B) protein aggregation and loss-of-function phenotype:** While protein aggregation can lead to a loss of function, the defining characteristic of a dominant-negative mutation in a dimer is the interference with the wild-type protein, not necessarily aggregation. While incorrectly formed dimers might aggregate, this is a potential secondary effect.\n    *   **C) loss of protein dimerization and wild-type phenotype:** This is incorrect. If the mutation caused a complete loss of the ability to dimerize, the mutant protein could not interfere with the wild-type protein. The wild-type proteins could still form functional dimers, likely resulting in a recessive, not dominant, phenotype. A dominant-negative effect requires interaction between the mutant and wild-type proteins.\n    *   **D) protein degradation and loss-of-function of the wild-type allele:** This is the most plausible molecular phenotype. The non-functional heterodimers (wild-type + mutant Y) that form are often unstable and targeted by the cell's quality control machinery for degradation. This process effectively removes the functional wild-type protein from the pool, leading to a loss-of-function of the wild-type allele's product. This accurately describes the molecular consequence of the dominant-negative mutation Y.\n\n<<<D>>>"
  ],
  "user_prompt_list": [
    "In an inactive state, a transcription factor subunit awaits an activation signal from the membrane phosphorylation cascade. Upon phosphorylation on the Ser residues in the transactivation domain, it dimerizes, shuttles into the nucleus, and serves in gene transcription. A missense mutation X in the transactivation domain is a recessive loss-of-function mutation. You observe that a heterozygous mutation Y in the dimerization domain acts as a dominant-negative mutation. Which of the following molecular phenotypes is most likely observed in the presence of mutation Y?\n\nA) change of protein conformation and gain-of-function phenotype\nB) protein aggregation and loss-of-function phenotype\nC) loss of protein dimerization and wild-type phenotype\nD) protein degradation and loss-of-function of the wild-type allele\n\nOnce you feel you are ready for the final answer, directly return the answer with the format <<<answer content>>> at the end of your response, e.g. <<<C>>>, <<<A>>>"
  ],
  "system_message": ""
}